Resource center, Investors Resource center, Investors20 April 2026parDIAGNOS Diagnos ADK uses AI and Telemedicine to Scan your Eye for Health Issues in 16 Countries 1 Post navigation Previous PostDIAGNOS annonce lexercice de bons de souscription et une mise a jour sur son encaisse Next PostEchelon Capital Markets DIAGNOS Inc. Initiating Coverage – Keep Your Eye on This AI Company Taking on the Leading Cause of Blindness 1 Ressources connexe <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS and CHUM are launching of the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 05 2022 DIAGNOS DIAGNOS and CHUM are launching of the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-24-at-00.28.18.webp" alt="DIAGNOS annonce un pilote avec Opticalia en Espagne" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Resource center Investors 07 2021 DIAGNOS DIAGNOS annonce un pilote avec Opticalia en Espagne Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-accelerera-la-demande-de-licence-dinstrument-medical-a-Sante-Canada-et-a-la-FDA-des-Etats-Unis-concernant-ses-4-nouveaux-modules-danalyse^J-et-prevoit-la-certification-ISO-27001" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 04 2024 DIAGNOS DIAGNOS accelerera la demande de licence dinstrument medical a Sante Canada et a la FDA des Etats Unis concernant ses 4 nouveaux modules danalyse^J et prevoit la certification ISO 27001 Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS and CHUM are launching of the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 05 2022 DIAGNOS DIAGNOS and CHUM are launching of the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-24-at-00.28.18.webp" alt="DIAGNOS annonce un pilote avec Opticalia en Espagne" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Resource center Investors 07 2021 DIAGNOS DIAGNOS annonce un pilote avec Opticalia en Espagne Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-accelerera-la-demande-de-licence-dinstrument-medical-a-Sante-Canada-et-a-la-FDA-des-Etats-Unis-concernant-ses-4-nouveaux-modules-danalyse^J-et-prevoit-la-certification-ISO-27001" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 04 2024 DIAGNOS DIAGNOS accelerera la demande de licence dinstrument medical a Sante Canada et a la FDA des Etats Unis concernant ses 4 nouveaux modules danalyse^J et prevoit la certification ISO 27001 Download PDF
